CAR-T cell therapy (CD19+)

Chimeric Antigen Receptor T-cell therapy targeting CD19

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAR-T cell therapy (CD19+), covering 2024-08-28 to 2024-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Pilot CAR-T Cells Therapy for Children/Young Adults With CD19+ R/R Leukemia/Lymphoma [Phase 1]